Reuters logo
BRIEF-Faron Pharmaceuticals says ‍traumakine receives PIM designation from MHRA
October 2, 2017 / 6:45 AM / 21 days ago

BRIEF-Faron Pharmaceuticals says ‍traumakine receives PIM designation from MHRA

Oct 2 (Reuters) - Faron Pharmaceuticals Oy:

* Traumakine receives pim designation from mhra​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below